Healthcare: How Amgen Could Side-Step The Sting of Patent Expiration

<p><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 16px; line-height: 24px;">Expiring patents threaten billions of dollars in sales at Amgen. </span><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 12pt; line-height: 24px;">Here's what the company is doing to offset the</span><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 12pt; line-height: 24px;"> threat to some of its best selling drugs.</span></p>